Consolidated Portfolio Review Corp’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,693
| Closed | -$260K | – | 451 |
|
|
2025
Q1 | $260K | Sell |
12,693
-123
| -1% | -$2.52K | 0.04% | 317 |
|
|
2024
Q4 | $290K | Sell |
12,816
-1,550
| -11% | -$35.1K | 0.05% | 305 |
|
|
2024
Q3 | $354K | Sell |
14,366
-112
| -0.8% | -$2.76K | 0.08% | 222 |
|
|
2024
Q2 | $335K | Buy |
14,478
+415
| +3% | +$9.6K | 0.08% | 217 |
|
|
2024
Q1 | $339K | Buy |
14,063
+808
| +6% | +$19.5K | 0.09% | 195 |
|
|
2023
Q4 | $305K | Buy |
13,255
+2,465
| +23% | +$56.7K | 0.07% | 232 |
|
|
2023
Q3 | $220K | Sell |
10,790
-2,572
| -19% | -$52.3K | 0.05% | 284 |
|
|
2023
Q2 | $312K | Sell |
13,362
-1,896
| -12% | -$44.3K | 0.07% | 223 |
|
|
2023
Q1 | $355K | Buy |
+15,258
| New | +$355K | 0.1% | 194 |
|